146 related articles for article (PubMed ID: 20123937)
1. The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
Rajkumar R; Mahesh R
J Psychopharmacol; 2010 Apr; 24(4):455-69. PubMed ID: 20123937
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
[TBL] [Abstract][Full Text] [Related]
3. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
Serretti A; Benedetti F; Zanardi R; Smeraldi E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
[TBL] [Abstract][Full Text] [Related]
4. Ion channels as potential targets for the treatment of depression.
Lodge NJ; Li YW
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):633-41. PubMed ID: 18729015
[TBL] [Abstract][Full Text] [Related]
5. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
Nandam LS; Jhaveri D; Bartlett P
Clin Exp Pharmacol Physiol; 2007; 34(5-6):546-51. PubMed ID: 17439430
[TBL] [Abstract][Full Text] [Related]
6. Analgesic effects of 5-HT3 receptor antagonists.
Riering K; Rewerts C; Zieglgänsberger W
Scand J Rheumatol Suppl; 2004; 119():19-23. PubMed ID: 15515407
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists.
Kovac AL
J Clin Anesth; 2006 Jun; 18(4):304-18. PubMed ID: 16797435
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
[TBL] [Abstract][Full Text] [Related]
9. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
Overstreet DH; Griebel G
Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
[TBL] [Abstract][Full Text] [Related]
11. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
Lucki I
J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
[TBL] [Abstract][Full Text] [Related]
12. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
Gardier AM
Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
[TBL] [Abstract][Full Text] [Related]
13. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
Rajkumar R; Pandey DK; Mahesh R; Radha R
Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Ramamoorthy R; Radhakrishnan M; Borah M
Behav Pharmacol; 2008 Feb; 19(1):29-40. PubMed ID: 18195592
[TBL] [Abstract][Full Text] [Related]
15. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
Price LH; Charney DS; Delgado PL; Goodman WK; Krystal JH; Woods SW; Heninger GR
J Clin Psychiatry; 1990 Apr; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
[TBL] [Abstract][Full Text] [Related]
16. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
Weisshaar E; Dunker N; Röhl FW; Gollnick H
Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
[TBL] [Abstract][Full Text] [Related]
17. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
18. Serotonin receptor subtypes: implications for psychopharmacology.
Cowen PJ
Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
[TBL] [Abstract][Full Text] [Related]
19. High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor.
Krzywkowski K; Davies PA; Feinberg-Zadek PL; Bräuner-Osborne H; Jensen AA
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):722-7. PubMed ID: 18184810
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
